Skip to main content
Clinical Trials/CTRI/2021/12/038403
CTRI/2021/12/038403
Not yet recruiting
Phase 2

â?? RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF NIMBAADI TAILA IN COMPARISION WITH EUSOL LIQUID IN THE MANAGEMENT OF DUSHTA VRANA

Vinod Patel0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Sponsor
Vinod Patel
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Vinod Patel

Eligibility Criteria

Inclusion Criteria

  • 1\)Both male and female.
  • 2\)Between the age group of 12 to 80 yrs will be included in the study.
  • 3\)Patients of dushtavrana with a minimum history of 3 weeks.
  • 4\)Dushtavrana size 5x5 (LxL)cms.
  • 5\) Selection is irrespective of religion, socio\-economical status an occupation.
  • 6\) Controlled diabetic patients.

Exclusion Criteria

  • 1 Patient not willing fortrial
  • 2 Patient who need surgical and other inintervention.
  • 3 Anaemic patient Hb \<10 gm
  • 4 Malnourished patient (as per age ,height and weight proportion.)
  • 5 Bleeding disorders (increased B.T and C.T)
  • 6 Patient with septicemia
  • 7 The patients suffering from systemic disease such as AIDS,Tuberculosis,Diabetes mellitus, Hepatitis\-B, Malignancy, Vericose ulcer, Deep vein
  • thrombosis,Arterial ulcer,Neurogenic ulcer, Leprosy, Pregnancy,Leukemia Acute
  • and Chronic renal failure,Jaundice and cirrhosis of liver, etc..
  • 8 Any congenital diseases or abnormalities.

Outcomes

Primary Outcomes

Not specified

Similar Trials